Old Web
English
Sign In
Acemap
>
authorDetail
>
M E Pape
M E Pape
Esperion Therapeutics Inc.
Biochemistry
Biology
Internal medicine
Endocrinology
Complementary DNA
5
Papers
188
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome
2004
Journal of Lipid Research
Clay T. Cramer
Brian Goetz
Krista L. Hopson
Gregory J. Fici
Rose Ackermann
Stephen C. Brown
Charles L. Bisgaier
W. G. Rajeswaran
Daniela C. Oniciu
M E Pape
Show All
Source
Cite
Save
Citations (47)
High density lipoprotein: are elevated levels desirable and achievable?
1998
Current Pharmaceutical Design
C. L. Bisgaier
M E Pape
Show All
Source
Cite
Save
Citations (7)
Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors
1997
Journal of Lipid Research
Charles L. Bisgaier
Arnold D. Essenburg
Bruce J. Auerbach
M E Pape
Catherine Sekerke
A. Gee
S Wölle
Roger S. Newton
Show All
Source
Cite
Save
Citations (71)
A cDNA-dependent scintillation proximity assay for quantifying apolipoprotein A-I.
1997
Journal of Lipid Research
Jeffrey C. Hanselman
D. A. Schwab
Thomas J. Rea
Charles L. Bisgaier
M E Pape
Show All
Source
Cite
Save
Citations (2)
1